Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Nove Mesto

5 clinical trials in Nove Mesto, Slovakia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Nove Mesto at a glance
5
clinical trials
  • Recruiting now0
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

5 trials in Nove Mesto

Open in trial search

Angina pectoris

Not yet recruiting
Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Glyceryl Trinitrate
  • Sponsor:Tasly Pharmaceuticals Inc.

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Atrial fibrillation

Not recruiting
Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen - Cilag International
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Camizestrant
  • Sponsor:AstraZeneca AB

Hypertriglyceridaemia

Not recruiting
Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Arrowhead Pharmaceuticals Inc.

Other cities in Slovakia

The busiest research cities in the country

All 92 cities in Slovakia

Clinical research in Nove Mesto

What the registry says about research in the country

01 Nove Mesto
Cardiovascular Diseases
Clinical trial activity in Nove Mesto includes research in cardiovascular diseases, with a focus on atrial fibrillation and stable angina pectoris. These studies are designed to assess new treatment options and confirm whether emerging therapies can better prevent complications or relieve symptoms. Prevention of cardioembolic events in atrial fibrillation Evaluation of anti-anginal effects in stable angina pectoris Testing treatment effectiveness for ongoing heart-related conditions Overall, this area reflects active work aimed at improving both protection from serious cardiovascular events and day-to-day symptom control.
Digestive System and Liver Disorders
Another important research focus is digestive system diseases, especially studies involving hepatic impairment and moderate or severe hepatic impairment. These trials look at how liver problems may affect the safety and behavior of investigational therapies, helping define whether treatments can be used more effectively in people with liver disease. Study of liver-related effects on treatment use Research involving hepatic impairment and liver problems Assessment of safety and tolerability in patients with compromised liver function This area supports safer prescribing decisions and better understanding of how new therapies perform in patients with liver conditions.
Nutritional and Metabolic Diseases
Trials in nutritional and metabolic diseases are centered on hypertriglyceridemia and severe hypertriglyceridemia, reflecting a clear effort to improve management of abnormal lipid levels. The research is mainly aimed at testing whether new therapies can lower triglycerides and support better metabolic health. Reduction of fasting serum triglyceride levels Studies in hypertriglyceridemia and severe hypertriglyceridemia Evaluation of treatment effectiveness for lipid-related disorders These studies are relevant for patients at risk of complications linked to elevated triglycerides and broader metabolic imbalance.
Unspecified Therapeutic Area
Some studies in the city span broader or not fully specified categories, but they still contribute to a diverse clinical research environment. The overall pattern suggests work across multiple medical fields, with a strong emphasis on evaluating new therapies, confirming benefits, and improving how existing conditions are managed. Broad clinical research across multiple disease areas Testing the value of emerging treatment approaches Supporting better disease management through clinical evaluation With several recruiting sites active, the local trial landscape in Slovakia remains focused on practical questions that matter for patient care.
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.